Home |  Contact Us | Site Map

Investor Relations

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.

Recent Releases

Jun 18, 2015
BioCryst to Present at the JMP Securities Life Sciences Conference

Jun 17, 2015
BioCryst Licenses Worldwide Rights to Commercialize RAPIVAB(R) Influenza Treatment to CSL Limited

View all releases »

Proxy Online

For more information click here.

Investor Relations

Rob Bennett, Vice President Investor Relations & Operations
919.859.7910
investorrelations@biocryst.com

Proxy Online

For more information click here.

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)

Stock Information
NASDAQ : BCRX
$15.10   + 0.54
Jul 2, 2015
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.